Stockscreener 앱 받기
84.76
0.69%
0.58
시간 외 거래:
84.77
0.010
+0.01%
전일 마감가:
$84.18
열려 있는:
$84.18
하루 거래량:
910.85K
Relative Volume:
1.16
시가총액:
$41.92B
수익:
$9.76B
순이익/손실:
$1.16B
주가수익비율:
117.72
EPS:
0.72
순현금흐름:
$665.00M
1주 성능:
+0.70%
1개월 성능:
-0.87%
6개월 성능:
-5.23%
1년 성능:
+13.41%
1일 변동 폭
$84.06
$85.33
1주일 범위
$83.80
$86.50
52주 변동 폭
$74.30
$101.10
Alcon Inc Stock (ALC) Company Profile
ALC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
84.76 | 41.92B | 9.76B | 1.16B | 665.00M | 2.34 |
|
ISRG
Intuitive Surgical Inc
|
524.43 | 186.79B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
227.68 | 65.83B | 20.18B | 1.71B | 3.07B | 5.94 |
|
RMD
Resmed Inc
|
237.27 | 34.83B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
331.40 | 24.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 재확인 | Needham | Buy |
| 2024-11-12 | 재확인 | Needham | Buy |
| 2024-10-10 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 개시 | Goldman | Buy |
| 2024-03-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 개시 | Bernstein | Outperform |
| 2023-12-18 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | 업그레이드 | Societe Generale | Sell → Hold |
| 2022-12-22 | 개시 | Mizuho | Buy |
| 2022-11-17 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2022-08-11 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-05-12 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-11 | 개시 | BofA Securities | Buy |
| 2022-01-18 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 개시 | Oppenheimer | Perform |
| 2021-07-14 | 개시 | Deutsche Bank | Buy |
| 2021-05-06 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-03-22 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-11-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-07-06 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-07-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-04-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Argus | Hold → Buy |
| 2020-03-24 | 업그레이드 | Societe Generale | Sell → Hold |
| 2020-03-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-26 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-01-08 | 개시 | Argus | Hold |
| 2019-10-29 | 개시 | Stephens | Equal-Weight |
| 2019-08-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-06-24 | 개시 | SVB Leerink | Mkt Perform |
| 2019-06-14 | 개시 | BTIG Research | Neutral |
| 2019-05-10 | 개시 | Robert W. Baird | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
모두보기
Alcon Inc 주식(ALC)의 최신 뉴스
Alcon a top pick for 2025 at Needham on upcoming product launches - MSN
Alcon Top Pick for 2025 at Needham, added to Conviction List - MSN
Alcon stock named top pick for 2025 by Needham, positive on margin and earnings growth - Investing.com
Ophthalmic Lasers Market, Competitive Landscape and Market Forecasts to 2030 - GlobeNewswire Inc.
RSI Alert: Alcon (ALC) Now Oversold - Nasdaq
Reasons to Retain Alcon Stock in Your Portfolio for Now - MSN
Does Alcon (VTX:ALC) Have A Healthy Balance Sheet? - Simply Wall St
Alcon Loses Bid To Patent Improved Eye Drug At EPO - Law360
Alcon to lay off dozens of food service workers at Fort Worth campus on Christmas Eve - Yahoo! Voices
Why Alcon (ALC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Alcon Inc. (ALC): A Bull Case Theory - MSN
Fuchs Endothelial Corneal Dystrophy Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | ProQR Therapeutics, Kowa Pharmac, Trefoil Therapeutics, Alcon Inc., Emmecell - Barchart
Photobiomodulation Market Overall Study Report 2024-2031 | - openPR
Dry Eye Disease Market Outlook to 2034: Insights into Epidemiology, Pipeline Developments, and Recent Regulatory Approvals by DelveInsight | Featuring Major Players Like Alcon, Allysta Pharmaceuticals - The Globe and Mail
Ocular Trauma Devices Market Is Booming Worldwide with Alcon, Zeiss, Santen - openPR
India Contact Lenses Market Forecasts and Company Analysis Report 2023-2024 & 2032 Featuring Bausch & Lomb, Alcon Laboratories, J&J, Cooper Vision, Carl Zeiss, Hoya Medical, GKB Ophthalmic and Omni - Yahoo Finance
State Rep. Alcon steps down, cites health concerns - New Mexico Political Report
Jesse Alcon Obituary (2024)Price, UTMitchell Funeral Home, Inc.Price - Legacy.com
Alcon, '3D eye model implementation'Personal vision correction'Personal Eyes' launched in Korea - SportsChosun
What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings - MSN
Alcon cuts 2024 forecasts, as slow US hits surgical unit - MSN
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours - MSN
Impressive Earnings May Not Tell The Whole Story For Alcon (VTX:ALC) - Yahoo Finance
Lights, Camera, Lawsuit: Musk and Tesla in Hot Water Over Claimed “Blade Runner” Rip-Off - JD Supra
Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Most Venture Investors Want Their Startups to Go Public. Not This One. - The Wall Street Journal
Alcon Laboratories is considering a major $100M expansion of its Fort Worth campus - AOL
Results: Alcon Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
Reiterate Overweight on Alcon with $107 target post 3Q results - Investing.com
Alcon Inc. (NYSE:ALC) Q3 2024 Earnings Call Transcript - Insider Monkey
Alcon shares maintain Buy rating and $107 target post-results By Investing.com - Investing.com Australia
Earnings call: Alcon reports solid Q3 growth, updates full-year guidance - Investing.com UK
Alcon: Q3, Slight Guidance Cut Is Not Something Structural - Seeking Alpha
Alcon Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
3 Focus Stocks: Alcon, Up Fintech, and Monolithic Power Systems - Baystreet.ca
ALCON : Q3 miss and an outlook downgrade should not be seen as worrisome - Marketscreener.com
Pharmaceuticals: Alcon records lower growth in the third quarter | blue News - bluewin E-Mail
Alcon Lowers Financial Outlook After US Sales Slump - Finimize
Alcon trims revenue forecast - 69News WFMZ-TV
Alcon shares maintain Buy rating and $107 target post-results - Investing.com
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation - sharewise
Alcon Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Alcon falls 6% as company trims 2024 sales outlook - MSN
Alcon Posts Higher 3Q Sales and Profit, Lowers 2024 Sales View - MarketWatch
Alcon’s Strong Q3 2024 Results Boost Investor Confidence - TipRanks
Cell therapy startup's IPO plans thrown in limbo amid legal spat with investor Alcon - Endpoints News
Alcon Inc (ALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.46%
자본화:
|
볼륨(24시간):